Anzeige
Mehr »
Freitag, 10.04.2026 - Börsentäglich über 12.000 News
Die Bohrer rollen - der Durchbruch-Moment ist da
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA3 | ISIN: US56270V2051 | Ticker-Symbol:
NASDAQ
09.04.26 | 21:59
0,345 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MANGOCEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MANGOCEUTICALS INC 5-Tage-Chart

Aktuelle News zur MANGOCEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.04.MANGOCEUTICALS, INC. - 10-K, Annual Report1
31.03.MANGOCEUTICALS, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4051
MANGOCEUTICALS Aktie jetzt für 0€ handeln
17.03.Mangoceuticals verklagt Technologie-Dienstleister auf 73 Millionen US-Dollar5
17.03.Mangoceuticals, Inc.: Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.304Dallas, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals," the "Company," or "MangoRx"), a company focused on developing, marketing, and selling health...
► Artikel lesen
17.03.MANGOCEUTICALS, INC. - 8-K, Current Report4
06.03.Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds284Dallas, TX, March 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine...
► Artikel lesen
23.02.Mangoceuticals: Aktie steigt nach positiven Daten zu antiviralem Geflügel-Wirkstoff2
23.02.Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study136Dallas, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine...
► Artikel lesen
19.02.MANGOCEUTICALS, INC. - 8-K, Current Report1
06.02.MANGOCEUTICALS, INC. - 8-K, Current Report1
23.01.MANGOCEUTICALS, INC. - S-1/A, General form for registration of securities1
13.01.MANGOCEUTICALS, INC. - S-1, General form for registration of securities1
19.12.25Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements3
19.12.25Mangoceuticals announces $100 million Solana-focused strategy2
19.12.25Mangoceuticals setzt auf Solana: Neue Treasury-Strategie über 100 Millionen US-Dollar1
19.12.25Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy7
19.12.25MANGOCEUTICALS, INC. - 8-K, Current Report1
18.12.25Mangoceuticals prices $2.5M registered direct offering with warrants1
18.12.25Mangoceuticals secures $2.5 million through registered direct offering4
18.12.25Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules1
Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1